AAAAAA

   
Results: 1-12 |
Results: 12

Authors: MIGLINO M CANEPA L PALMISANO G CLAVIO M CELESTI L SPRIANO M PIERRI I VALLEBELLA E CARRARA P CAVALIERE M PIETRASANTA D BALLERINI F BELTRAMI G SANTINI G DAMASIO E GOBBI M
Citation: M. Miglino et al., MOLECULAR STUDY OF COMPLETE REMISSION IN CHRONIC LYMPHOPROLIFERATIVE DISORDERS AFTER FIRST LINE FLUDARABINE THERAPY, Experimental hematology, 25(8), 1997, pp. 623-623

Authors: CLAVIO M ROSSI E TRUINI M CARRARA P RAVETTI JL SPRIANO M VIMERCATI AR SANTINI G CANEPA L PIERRI I CELESTI L MIGLINO M CASTELLANETA A DAMASIO E GOBBI M
Citation: M. Clavio et al., ANAPLASTIC LARGE-CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 53 PATIENTS, Leukemia & lymphoma, 22(3-4), 1996, pp. 319-327

Authors: VISANI G TOSI P ZINZANI PL MANFROI S OTTAVIANI E CENACCHI A CARRARA P CLAVIO M GOBBI M TURA S
Citation: G. Visani et al., FLAG (FLUDARABINE, CYTARABINE, G-CSF) AS A 2ND LINE THERAPY FOR ACUTELYMPHOBLASTIC-LEUKEMIA WITH MYELOID ANTIGEN EXPRESSION - IN-VITRO ANDIN-VIVO EFFECTS, European journal of haematology, 56(5), 1996, pp. 308-312

Authors: CLAVIO M CARRARA P MIGLINO M PIERRI I CANEPA L BALLEARI E GATTI AM CERRI R CELESTI L VALLEBELLA E SESSAREGO M PATRONE F GHIO R DAMASIO E GOBBI M
Citation: M. Clavio et al., HIGH EFFICACY OF FLUDARABINE-CONTAINING THERAPY (FLAG-FLANG) IN POOR-RISK ACUTE MYELOID-LEUKEMIA, Haematologica, 81(6), 1996, pp. 513-520

Authors: GOBBI M CLAVIO M MIGLINO M CARRARA P BALLEARI E CERRI R PIERRI I CANEPA L CELESTI L VALLEBELLA E CAVALIERE M PIETRASANTA D GENNARO M GHIO R DAMASIO E
Citation: M. Gobbi et al., FLUDARABINE, ARA-C, G-CSF WITH OR WITHOUT MITOXANTRONE (FLANG-FLAG) ARE TOLERABLE AND EFFECTIVE IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA PATIENTS, Experimental hematology, 24(9), 1996, pp. 585-585

Authors: GOBBI M CLAVIO M PIERRI I CANEPA L MIGLINO M CELESTI L CARRARA P GATTI AM VALLEBELLA E PIETRASANTA D CAVALIERE M DAMASIO E GHIO R
Citation: M. Gobbi et al., SHORT, INTENSIVE FLUDARABINE CONTAINING INDUCTION THERAPY (FLAG-FLANG) IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA, Blood, 88(10), 1996, pp. 863-863

Authors: CARRARA P CLAVIO M PIERRI I CANEPA L MIGLINO M CELESTI L RISSO M GOBBI M
Citation: P. Carrara et al., CLINICAL-APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS, FCI. Fundamental and clinical immunology, 2(2), 1994, pp. 107-111

Authors: VISANI G TOSI P ZINZANI PL MANFROI S OTTAVIANI E TESTONI N CLAVIO M CENACCHI A GAMBERI B CARRARA P GOBBI M TURA S
Citation: G. Visani et al., FLAG (FLUDARABINE PLUS HIGH-DOSE CYTARABINE PLUS G-CSF) - AN EFFECTIVE A ND TOLERABLE PROTOCOL FOR THE TREATMENT OF POOR-RISK ACUTE MYELOIDLEUKEMIAS, Leukemia, 8(11), 1994, pp. 1842-1846

Authors: CLAVIO M CARRARA P SPRIANO M PIERRI I CANEPA L MIGLINO M CELESTI L ROSSI E GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Clavio et al., FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 257-263

Authors: CLAVIO M CARRARA P SPRIANO M PIERRI I CANEPA L MIGLINO M CELESTI L ROSSI E GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Clavio et al., FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 257-263

Authors: SPRIANO M CLAVIO M CARRARA P CANEPA L MIGLINO M PIERRI I CELESTI L ROSSI E VIMERCATI R BRUNI R SANTINI G GATTI AM STURA P GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Spriano et al., FLUDARABINE IN UNTREATED AND PREVIOUSLY TREATED B-CLL PATIENTS - A REPORT ON EFFICIENCY AND TOXICITY, Haematologica, 79(3), 1994, pp. 218-224

Authors: MIGLINO M PIERRI I CANEPA L CARRARA P CELESTI L GOBBI M
Citation: M. Miglino et al., AN UNUSUAL REACTION TO ALPHA-INTERFERON IN A CASE OF NON-HODGKINS-LYMPHOMA, Haematologica, 78(6), 1993, pp. 411-413
Risultati: 1-12 |